In celebration of National Diabetes Awareness Month, Yoda Diagnostics has launched its impactful 'Beat the Diabetes' campaign, which aims to highlight the need for personalized approaches to managing diabetes through customized medication plans. This pioneering initiative seeks to address the unique medical needs of individuals living with diabetes by promoting the Yoda Pharmacogenomics (PGx) test, an advanced diagnostic tool that leverages cutting-edge genetic insights to optimize treatment. By tailoring medication to each patient's genetic profile, Yoda Diagnostics aims to enhance the effectiveness of treatments and minimize the risk of side effects, ensuring that diabetic patients receive the most appropriate and safe care for their condition.
Diabetes remains a critical health issue in India, where an estimated 77 million adults currently live with the disease. The World Health Organization (WHO) predicts that this number could rise to over 124 million by 2045, making diabetes one of the most pressing health challenges facing the country. Unfortunately, a large percentage of people with diabetes in India are undiagnosed, untreated, or at risk of complications due to improper management of the condition. A recent study published in the Journal of the Indian Institute of Science revealed that over 50% of diabetic patients in India are prescribed the wrong medications, which increases the likelihood of adverse reactions and inefficient management. This underscores the need for more accurate, personalized treatments to ensure better care for those living with diabetes.
Recognizing these gaps in care, Yoda Diagnostics has introduced the ‘Beat the Diabetes’ campaign to raise awareness about the importance of personalized diabetes care. At the heart of the campaign is the Yoda PGx test, which offers a distinct advantage over traditional one-size-fits-all treatments. Rather than relying on generic medications, the Yoda PGx test analyzes a patient’s genetic makeup to identify the most effective drugs for their unique biological profile. This personalized approach aims to minimize the occurrence of adverse side effects and ensures that patients receive treatment that is more likely to deliver the desired results, ultimately leading to better management of their diabetes.
Sudhakar Kancharla, the CEO of Yoda Diagnostics, shared his vision for the campaign: “The ‘Beat the Diabetes’ campaign was created to empower diabetes patients by encouraging them to take the Yoda PGx test. Our goal is to improve treatment efficiency and safety through customized medication strategies. The Yoda PGx test can save patients time and money by avoiding ineffective treatments, while also enhancing their quality of life through improved treatment response and satisfaction. With personalized care, we can help people live healthier, longer lives, minimizing the complications associated with diabetes.”
As part of the 'Beat the Diabetes' initiative, Yoda Diagnostics offers two critical panels that focus on optimizing diabetes management:
-
Diabetes & Cardiovascular PGx Panel: This comprehensive panel assesses genetic factors that influence both diabetes and cardiovascular health, offering a more holistic approach to treatment optimization for patients who may have co-existing health issues. Since diabetes and cardiovascular diseases often go hand in hand, this test provides tailored insights into the best treatment strategies for individuals with these interconnected conditions.
-
Diabetes PGx Panel: Specifically focused on diabetes, this test examines genetic markers that determine which medications will work best for the individual. By identifying the most effective drugs, this panel helps reduce the risks associated with adverse drug reactions and provides a more reliable and targeted treatment plan that can improve the overall management of diabetes.
In addition to the Yoda PGx test, Yoda Diagnostics is also promoting preventive care by offering a Diabetes Panel Comprehensive, a routine screening tool that helps in the early diagnosis of diabetes. Early detection is crucial in preventing complications such as kidney disease, nerve damage, and vision problems. By encouraging early screening, Yoda Diagnostics aims to enable proactive management of diabetes and reduce the long-term risks associated with delayed diagnosis.
The 'Beat the Diabetes' campaign is open to all individuals who are interested in taking a more active role in managing their diabetes. Interested participants are encouraged to reach out to Yoda Diagnostics’ customer care team at 9135353535 or visit the company’s website for additional information about the tests and the campaign. The campaign will run until November 30, 2024, providing ample time for individuals to learn more about how the Yoda PGx test and other diagnostic tools can significantly improve their treatment plans.
Yoda Diagnostics, founded in 2021 in Hyderabad, is committed to providing high-quality, affordable diagnostic services. The company utilizes AI-driven technology sourced from the United States and adopts a patient-centered approach, ensuring that each test is accurate and reliable. Yoda Diagnostics is accredited by both NABL (National Accreditation Board for Testing and Calibration Laboratories) and ISO (International Organization for Standardization), meeting international quality standards. The company’s tests boast an impressive 90% accuracy rate, which further solidifies its reputation as a trusted provider of diagnostic solutions.
In addition to its advanced testing capabilities, Yoda Diagnostics offers free pre- and post-test genetic counseling to help patients fully understand their results and make informed decisions about their healthcare. With a network of six branches and over 25 collection centers across India, Yoda Diagnostics makes testing accessible to a broad audience. For added convenience, the company also offers home sample collection services and nationwide shipping for testing kits, allowing patients to complete their tests from the comfort of their homes. This patient-centric approach ensures that healthcare is more accessible, convenient, and efficient, providing an end-to-end solution for people looking to manage their diabetes more effectively.
Yoda Diagnostics’ commitment to improving diabetes care through personalized treatment plans and cutting-edge genetic testing is a step towards a healthier, more informed future for diabetic patients. Through the ‘Beat the Diabetes’ campaign, the company hopes to educate and empower individuals to take charge of their health and receive care that is tailored to their unique genetic makeup.
